Alzheimer's disease (AD) is a progressive, multifactorial, and unremitting neurodegenerative
disease characterized by memory loss, personality changes, and cognitive impairment. It …

Alzheimer's disease (AD) is a neurological condition currently with 47 million people
suffering from it globally. AD might have many reasons such as genetic issues …

The complex pathological mechanism of Alzheimer's disease (AD) limits the efficacy of
simple drug therapy, and drugs are difficult to penetrate the blood‐brain barrier (BBB) …

Alzheimer's disease (AD) is the most common neurodegenerative disorder worldwide.
Because of the complex pathogenesis of AD and the unique location of AD lesions, effective …

Neurodegenerative disorders (NDDs) such as Alzheimer's (AD) and Parkinson's (PD) are on
the rise, robbing people of their memories and independence. While risk factors such as age …

Background Alzheimer's disease (AD) is characterized by neuroinflammation linked to
amyloid β (Aβ) aggregation and phosphorylated tau (τ) protein in neurofibrillary tangles …

In this study, 50 SD adult male mice were used to create an Alzheimer's disease model. The
mice's learning and memory abilities were evaluated using an eight-arm radial maze …

Alzheimer's disease is a neurological disorder that causes increased memory loss, mood
swings, behavioral disorders, and disruptions in daily activities. Polymer scaffolds for the …

Currently, there is an inherent contradiction between the multifunctionality and excellent
biocompatibility of anticancer drug nanocarriers, which limits their application. Therefore, to …

Alzheimer's disease (AD) is a neuropathology characterized by progressive cognitive
impairment and dementia. The disease is attributed to senile plaques, which are aggregates …